Patent 9603863 was granted and assigned to Alios BioPharma, Inc. on March, 2017 by the United States Patent and Trademark Office.
Disclosed herein are nucleosides, nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a Filoviridae virus infection with one or more nucleosides and/or nucleotide analogs.